Clinical Trial Detail

NCT ID NCT03655756
Title pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Morphogenesis, Inc.
Indications

melanoma

Therapies

IFx-Hu2.0

Age Groups: adult senior

No variant requirements are available.